HealthEquity, Inc. (NASDAQ:HQY) Stock Holdings Boosted by New York State Teachers Retirement System

New York State Teachers Retirement System raised its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 83,997 shares of the company’s stock after buying an additional 1,146 shares during the period. New York State Teachers Retirement System owned about 0.10% of HealthEquity worth $6,875,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of HQY. Truist Financial Corp boosted its position in HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after acquiring an additional 188 shares during the period. O Shaughnessy Asset Management LLC increased its stake in shares of HealthEquity by 3.9% in the first quarter. O Shaughnessy Asset Management LLC now owns 5,219 shares of the company’s stock worth $426,000 after purchasing an additional 197 shares during the period. Nisa Investment Advisors LLC lifted its position in shares of HealthEquity by 7.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock worth $246,000 after purchasing an additional 198 shares during the last quarter. Elk River Wealth Management LLC boosted its stake in HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock valued at $5,417,000 after purchasing an additional 217 shares during the period. Finally, CWM LLC grew its holdings in HealthEquity by 6.9% in the 2nd quarter. CWM LLC now owns 3,958 shares of the company’s stock valued at $341,000 after buying an additional 255 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HealthEquity news, Director Frank Corvino sold 1,247 shares of the firm’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares in the company, valued at approximately $387,093.98. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Frank Corvino sold 1,247 shares of the business’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares in the company, valued at $387,093.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Robert W. Selander sold 8,250 shares of the company’s stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HQY shares. JMP Securities restated a “market outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America decreased their price objective on HealthEquity from $105.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, Barrington Research reissued an “outperform” rating and issued a $105.00 price target on shares of HealthEquity in a report on Friday, September 20th. Twelve analysts have rated the stock with a buy rating, According to MarketBeat.com, HealthEquity has an average rating of “Buy” and a consensus price target of $103.83.

HealthEquity Price Performance

Shares of HealthEquity stock opened at $86.95 on Tuesday. The stock has a market capitalization of $7.59 billion, a price-to-earnings ratio of 72.46, a P/E/G ratio of 1.33 and a beta of 0.52. The firm’s 50-day moving average price is $81.44 and its two-hundred day moving average price is $79.96. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $89.23.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. On average, equities analysts predict that HealthEquity, Inc. will post 2.27 earnings per share for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.